Wildflower Brands Inc. Share Price Canadian Securities Exchange
Equities
SUN
CA96812N1050
Pharmaceuticals
Sales 2018 | 1.41 1.92 108.54 | Sales 2019 | 7.09 9.69 546.13 | Capitalization | 63.9M 87.35M 4.93B |
---|---|---|---|---|---|
Net income 2018 | -7M -9.57M -540M | Net income 2019 | -4M -5.47M -308M | EV / Sales 2018 | 44,908,398 x |
Net Debt 2018 | 7.85M 10.74M 605M | Net Debt 2019 | 7.32M 10M 564M | EV / Sales 2019 | 10,051,719 x |
P/E ratio 2018 |
-6.99
x | P/E ratio 2019 |
-6.61
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
William MacLean
CEO | Chief Executive Officer | - | 17/06/14 |
Stephen Pearce
DFI | Director of Finance/CFO | 54 | 29/08/13 |
Myron van Snick
COO | Chief Operating Officer | - | 12/04/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Pearce
DFI | Director of Finance/CFO | 54 | 29/08/13 |
William MacLean
CEO | Chief Executive Officer | - | 17/06/14 |
Director/Board Member | - | 05/04/18 |
1st Jan change | Capi. | |
---|---|---|
+9.94% | 4.99B | |
-32.21% | 3.61B | |
-1.43% | 3.1B | |
-25.09% | 2.64B | |
-11.46% | 2.32B | |
+36.65% | 1.85B | |
+37.15% | 1.43B | |
-16.01% | 1.39B | |
+40.95% | 1.37B |